TY - JOUR
T1 - Curative Transvenous Embolization for Ruptured Brain Arteriovenous Malformations
T2 - A Single-Center Experience from China
AU - He, Yingkun
AU - Bai, Weixing
AU - Li, Tianxiao
AU - Hui, Ferdinand K.
AU - He, Yanyan
AU - Xu, Bin
N1 - Funding Information:
Conflict of interest statement: This work was supported by the National Natural Science Foundation of China (No. 81601583).
Publisher Copyright:
© 2018 The Authors
PY - 2018/8
Y1 - 2018/8
N2 - Objective: To evaluate feasibility and safety of transvenous embolization for brain arteriovenous malformations (AVMs). Methods: Between November 2016 and August 2017, a transvenous endovascular embolization protocol was implemented at the Henan Provincial People's Hospital for consecutive patients with ruptured brain AVMs. Therapeutic decision making was based on Spetzler-Martin grade, brain AVM location, pattern of venous drainage, and angioarchitecture. Transvenous embolization was combined with transarterial support. Complete angiographic obliteration of the nidus was the objective of treatment. Results: Among 10 patients with ruptured brain AVMs, 8 were male. Spetzler-Martin grades before transvenous embolization were IV in 3 patients, III in 5 patients, II in 1 patient, and I in 1 patient. Modified Rankin Scale score before the procedure was 0–2 for 6 of 10 patients. Five patients also had deep venous drainage. Arterial blood pressure control and venous pressure cooker technique were used in all 10 patients; 9 patients had immediate angiographic occlusion. Two patients had a ventricular hemorrhage, which did not cause any disability after medical treatment. Seven patients underwent angiography 3–5 months after the procedure, and complete obliteration of the nidus was confirmed. Median clinical follow-up for all 10 patients was 8 months (range, 3–12 months). Epilepsy occurred in 1 patient 3 months after the procedure, and modified Rankin Scale scores for all patients were ≤1. Conclusions: Transvenous embolization of brain AVMs is feasible and may improve cure rates. The safety and long-term effects need further validation.
AB - Objective: To evaluate feasibility and safety of transvenous embolization for brain arteriovenous malformations (AVMs). Methods: Between November 2016 and August 2017, a transvenous endovascular embolization protocol was implemented at the Henan Provincial People's Hospital for consecutive patients with ruptured brain AVMs. Therapeutic decision making was based on Spetzler-Martin grade, brain AVM location, pattern of venous drainage, and angioarchitecture. Transvenous embolization was combined with transarterial support. Complete angiographic obliteration of the nidus was the objective of treatment. Results: Among 10 patients with ruptured brain AVMs, 8 were male. Spetzler-Martin grades before transvenous embolization were IV in 3 patients, III in 5 patients, II in 1 patient, and I in 1 patient. Modified Rankin Scale score before the procedure was 0–2 for 6 of 10 patients. Five patients also had deep venous drainage. Arterial blood pressure control and venous pressure cooker technique were used in all 10 patients; 9 patients had immediate angiographic occlusion. Two patients had a ventricular hemorrhage, which did not cause any disability after medical treatment. Seven patients underwent angiography 3–5 months after the procedure, and complete obliteration of the nidus was confirmed. Median clinical follow-up for all 10 patients was 8 months (range, 3–12 months). Epilepsy occurred in 1 patient 3 months after the procedure, and modified Rankin Scale scores for all patients were ≤1. Conclusions: Transvenous embolization of brain AVMs is feasible and may improve cure rates. The safety and long-term effects need further validation.
KW - Brain arteriovenous malformation
KW - Embolization
KW - Internal jugular vein approach
UR - http://www.scopus.com/inward/record.url?scp=85047757775&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047757775&partnerID=8YFLogxK
U2 - 10.1016/j.wneu.2018.04.223
DO - 10.1016/j.wneu.2018.04.223
M3 - Article
C2 - 29753079
AN - SCOPUS:85047757775
SN - 1878-8750
VL - 116
SP - e421-e428
JO - World neurosurgery
JF - World neurosurgery
ER -